Cisbio develops and markets products and technologies used for in vitro diagnostics and drug discovery. With its proprietary technology, HTRF®, the company is a leader in homogeneous fluorescence detection methods and offers first class assays and services for drug discovery researchers. Cisbio operates globally and enables basic research and drug discovery projects to move faster, with the support of its scientific experts.Drop by our booth, discover Cisbio's assays for a broad range of therapeutic targets and readouts, and see how we make daily science easier.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. For over 25 years, our innovative tools have been used to obtain, analyze, and utilize cells. 2,000 employees in 15 international locations are dedicated to helping researchers and clinicians make a greater impact on science and health
Sponsors & Exhibitors
iOnctura is a biopharmaceutical company developing a pipeline of next-generation molecules for the treatment of cancer and fibrosis. With programs harnessing both immune-mediated and direct anti-tumor activity iOnctura aims to deliver superior clinical efficacy in oncology and build on complementary mechanisms between cancer and fibrosis. iOnctura will be the first company to clinically evaluate single-agent immuno-modulatory effects of a specific Pi3Kd inhibitor and an Autotaxin inhibitor in solid tumors.
Myriad RBM, Inc is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services. Myriad RBM’s internally developed and manufactured immunoassay kits based on Multi-Analyte Profiling (MAP) and ultrasensitive Single-Molecule Array (SimoaTM) technology, provide reproducible and quantitative data for hundreds of human proteins.
Based in Copenhagen, Denmark, Immudex manufactures MHC Dextramers for the detection of antigen-specific T cells in life science research, in vitro diagnostics, and the development of immunotherapeutics and vaccines. Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.
NEBION provides scientists and biomedical researchers with GENEVESTIGATOR®, the premier application for the meta-analysis of public and private gene expression data. Users particularly appreciate the high quality of curated data in combination with the intuitive data mining tools, which they use for the identification and characterization of novel biomarkers and drug targets, prediction of side effects and drug repurposing. Besides the constant expansion and development of GENEVESTIGATOR®, NEBION offers transcriptomics data curation and analysis services.
TransCure bioServices is the only CRO specialized in full human immune system mouse disease models for Cancer, Infectious, Inflammation and Vaccines.
Customers access these full services (protocol design, raw data collection, analysis, reports) in our BSL-2 and BSL-3 animal and laboratory technology (flow cytometry, cell biology) facilities on a very attractive fee-for-service basis.
Highest needs for large pharmaceutical and biotechnology companies as well as academic laboratories which can profile new preclinical/clinical drug candidates (small molecules, peptides, biologics, mAb, vaccines) targeting immuno-related diseases such as inflammation, cancer, or infectious diseases. TransCure bioServices is your one stop shop for in vivo pharmacology preclinical expertise.